This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1931 and headquartered in Northbrook, Illinois, The Allstate Corporation is the third-largest property-casualty (P&C) insurer and the largest publicly-held personal lines carrier in the U.S. The company also provides a range of life insurance and investment products to its diverse customer base. It provides insurance products to approximately 16 million households through more than 12,000 exclusive agencies and financial specialists in the U.S. and Canada.
Allstate (ALL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of 47.30% and 18.90%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Allstate (ALL) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Allstate's (ALL) Q2 earnings are expected to benefit from increase in revenues, partly offset by catastrophe losses.
Analysts Estimate Allstate (ALL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Allstate (ALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Research Reports for Chevron, Merck & Walgreens Boots
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Chevron (CVX), Merck (MRK) and Walgreens Boots (WBA).
Allstate (ALL) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Allstate (ALL) Expects to Incur Catastrophe Loss in May
by Zacks Equity Research
Being a relatively large property insurance business, Allstate (ALL) is significantly exposed to catastrophic events
Can Value Investors Pick Allstate Corporation (ALL) Stock?
by Zacks Equity Research
Allstate Corporation (ALL) stock may be a good choice for value-oriented investors right now from multiple angles.
Allstate (ALL) Rides on Growth in Premiums and Acquisitions
by Zacks Equity Research
A number of acquisitions made in the recent years have diversified Allstate's business profile, leading to premium growth.
Zacks Value Trader Highlights: Arch Capital, CAN, Allstate, Progressive and Travelers
by Zacks Equity Research
Zacks Value Trader Highlights: Arch Capital, CAN, Allstate, Progressive and Travelers
Allstate (ALL) Down 2.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Hide Out in Cheap Insurance Stocks?
by Tracey Ryniec
Insurance may seem boring but there's a reason its been around for hundreds of years. Are the fundamentals still solid?
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Allstate (ALL) Expects to Incur Catastrophe Loss for April
by Zacks Equity Research
Allstate (ALL) expects to incur $290 million pre-tax catastrophe loss for April, which can be attributed to seven weather-related events.
Why Allstate (ALL) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Allstate (ALL) Q1 Earnings Beat Despite Catastrophe Loss
by Zacks Equity Research
Allstate's (ALL) Q1 results benefit from increase in revenues, partly offset by loss due to catastrophe.
Allstate (ALL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of 0.44% and 15.22%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Allstate (ALL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Allstate (ALL) Q1 earnings to benefit from higher revenues, partly offset by rise in expenses.
What Awaits Intercontinental Exchange (ICE) in Q1 Earnings?
by Zacks Equity Research
Intercontinental Exchange's (ICE) first-quarter results are likely to benefit from a broad range of risk management services on an integrated platform
CME Group (CME) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CME Group (CME) is likely to benefit from expansion of futures products in emerging markets, options business, non-transaction related opportunities and OTC offerings.
MetLife (MET) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Revenue growth, cost-savings efforts to aid MetLife's (MET) earnings in Q1, which will be partly offset by lower investment income.
What's in Store for Lincoln National (LNC) in Q1 Earnings?
by Zacks Equity Research
Lincoln National (LNC) Q1 earnings to gain from higher revenues, partly offset by rise in expenses.
CNA Financial (CNA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
CNA Financial's (CNA) first-quarter results are likely to benefit from solid performances from its segments - Commercial and Specialty.
Allstate (ALL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Allstate (ALL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights: Roche, Danaher, BlackRock, Kinder Morgan and Allstate
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Roche, Danaher, BlackRock, Kinder Morgan and Allstate